Haby M, Reveiz L, Thomas R, Jordan H
J Public Health Policy. 2025; 46(1):193-210.
PMID: 39799247
PMC: 11893451.
DOI: 10.1057/s41271-024-00535-9.
Zechmeister-Koss I, Gotz G, Fabian D, Wild C
Int J Technol Assess Health Care. 2024; 40(1):e51.
PMID: 39498481
PMC: 11563174.
DOI: 10.1017/S0266462324000503.
Ladin K, Cuddeback J, Kenrik Duru O, Goel S, Harvey W, Park J
NPJ Digit Med. 2024; 7(1):290.
PMID: 39427028
PMC: 11490638.
DOI: 10.1038/s41746-024-01245-y.
Jansen M, Moynihan K, Taylor L, Basu S
J Bioeth Inq. 2024; .
PMID: 39365394
DOI: 10.1007/s11673-024-10381-9.
Pagano L, Glenn N, Hutchinson K, Long J, Braithwaite J, Sarkies M
Int J Equity Health. 2024; 23(1):167.
PMID: 39169362
PMC: 11337736.
DOI: 10.1186/s12939-024-02249-6.
The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan.
Baltussen R, Jansen M, Akhtar S, Bijlmakers L, Torres-Rueda S, Khalid M
Int J Health Policy Manag. 2024; 13:8004.
PMID: 39099516
PMC: 10699818.
DOI: 10.34172/ijhpm.2023.8004.
Costing Interventions for Developing an Essential Package of Health Services: Application of a Rapid Method and Results From Pakistan.
Raza W, Zulfiqar W, Shah M, Huda M, Akhtar S, Aqeel U
Int J Health Policy Manag. 2024; 13:8006.
PMID: 39099514
PMC: 11607593.
DOI: 10.34172/ijhpm.2023.8006.
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges.
Espinosa O, Rodriguez-Lesmes P, Romano G, Orozco E, Basto S, Avila D
Appl Health Econ Health Policy. 2024; 22(6):797-804.
PMID: 38995492
PMC: 11470905.
DOI: 10.1007/s40258-024-00900-5.
Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol.
Ngorsuraches S, Lai T, Habermann R, Wheeler Y, Meador W
Pharmacoecon Open. 2024; 8(5):773-781.
PMID: 38982030
PMC: 11362406.
DOI: 10.1007/s41669-024-00509-3.
Health technology assessment for sexual reproductive health and rights benefits package design in sub-Saharan Africa: A scoping review of evidence-informed deliberative processes.
Simangolwa W, Mbonigaba J, Govender K
PLoS One. 2024; 19(6):e0306042.
PMID: 38935794
PMC: 11210850.
DOI: 10.1371/journal.pone.0306042.
COVID-19 critical care triage across Canada: a narrative synthesis and ethical analysis of early provincial triage protocols.
Andersen S, Gamble N, Rewa O
Can J Anaesth. 2024; 71(8):1126-1136.
PMID: 38589739
PMC: 11269410.
DOI: 10.1007/s12630-024-02744-y.
Ethical preparedness in genomic medicine: how NHS clinical scientists navigate ethical issues.
Sahan K, Lyle K, Carley H, Hallowell N, Parker M, Lucassen A
J Med Ethics. 2024; 50(8):517-522.
PMID: 38320848
PMC: 11287646.
DOI: 10.1136/jme-2023-109692.
Ethical dilemmas in prioritizing patients for scarce radiotherapy resources.
DeBoer R, Ho A, Mutoniwase E, Nguyen C, Umutesi G, Bigirimana J
BMC Med Ethics. 2024; 25(1):12.
PMID: 38297294
PMC: 10829165.
DOI: 10.1186/s12910-024-01005-3.
The Critical Care Society of Southern Africa Consensus Guideline on ICU Triage and Rationing (ConICTri).
Joynt G, Gopalan P, Argent A, Chetty S, Wise R, Lai V
South Afr J Crit Care. 2023; 35(1b).
PMID: 37719328
PMC: 10503493.
DOI: 10.7196/SAJCC.2019.v35i1b.380.
The Critical Care Society of Southern Africa Consensus Statement on ICU Triage and Rationing (ConICTri).
Joynt G, Gopalan P, Argent A, Chetty S, Wise R, Lai V
South Afr J Crit Care. 2023; 35(1b).
PMID: 37719327
PMC: 10503494.
DOI: 10.7196/SAJCC.2019.v35.i1b.383.
Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
Roitberg F, Amaral T, Cherny N, Giuliani R, Latino N, Galotti M
ESMO Open. 2023; 8(5):101617.
PMID: 37672862
PMC: 10594014.
DOI: 10.1016/j.esmoop.2023.101617.
Patient, carer and family experiences of seeking redress and reconciliation following a life-changing event: Systematic review of qualitative evidence.
Shaw L, Lawal H, Briscoe S, Garside R, Thompson Coon J, Rogers M
Health Expect. 2023; 26(6):2127-2150.
PMID: 37452516
PMC: 10632635.
DOI: 10.1111/hex.13820.
Deliberative processes in health technology assessment of medicines: the case of Spain.
Pinilla-Dominguez P, Pinilla-Dominguez J
Int J Technol Assess Health Care. 2023; 39(1):e50.
PMID: 37403252
PMC: 11569961.
DOI: 10.1017/S0266462323000387.
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines.
Zarkavelis G, Amylidi A, Verbaanderd C, Cherny N, Metaxas Y, de Vries E
ESMO Open. 2023; 8(1):100604.
PMID: 36870739
PMC: 10024100.
DOI: 10.1016/j.esmoop.2022.100604.
COVID-19 Pandemic and Public Health Ethics in Japan.
Nakazawa E
JMA J. 2023; 6(1):76-80.
PMID: 36793519
PMC: 9908374.
DOI: 10.31662/jmaj.2022-0119.
